Other genes that showed marginal elevation after Pgp3-treatment include interleukin-1 receptor-associated kinase 2 (IRAK2), promyelocytic leukemia (PML), ephrin A1 (EFNA1), Alkb homolog 3, alpha-ketoglutarate dependent dioxygenase (ALKBH3), as well as STAT3, at 0.56- (P = 0.00189), 0.56- (P = 0.0055), 0.49- (P = 0.0313), 0.18- (P = 0.0331), and 0.15-fold (P = 0.0223) respectively. This evidence concerns the gene ALKBH3 and leukemia.